Evidence map›Paper›PMID 39252854›Full record

ArticleAmerican journal of preventive cardiology2024

Integrating cardiovascular risk assessment into mobile low-dose CT lung screenings in rural Appalachia: A comprehensive analysis of the relationship between lung cancer risk, coronary artery calcium burden, and cardiovascular risk reduction strategies.

Seher Berzingi, Kara Piechowski, Emily Hendricks, Mark Colantonio, Asuwin Anandarm, Gregory Perkowski, Tyler Miller, Justin Conte, Sameh Nassar, Belal Kaseer and 4 more

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Seher BerzingiDepartment of Medicine, West Virginia University (WVU) School of Medicine, Morgantown, WV, USA.
Kara PiechowskiMarshall University, Joan C. Edwards School of Medicine, Huntington, WV, USA.
Emily HendricksDepartment of Medicine, West Virginia University (WVU) School of Medicine, Morgantown, WV, USA.
Mark ColantonioDepartment of Medicine, West Virginia University (WVU) School of Medicine, Morgantown, WV, USA.
Asuwin AnandarmWest Virginia University (WVU) Medicine, Morgantown, WV, USA.
Gregory PerkowskiWest Virginia University (WVU) Medicine, Morgantown, WV, USA.
Tyler MillerWest Virginia University (WVU) Medicine, Morgantown, WV, USA.
Justin ConteDepartment of Medicine, West Virginia University (WVU) School of Medicine, Morgantown, WV, USA.
Sameh NassarWest Virginia University (WVU) Medicine, Morgantown, WV, USA.
Belal KaseerWest Virginia University (WVU) Medicine, Morgantown, WV, USA.
Marcelino Mederos LirianoDepartment of Medicine, West Virginia University (WVU) School of Medicine, Morgantown, WV, USA.
Juan Carlo AvalonWest Virginia University (WVU) Medicine, Morgantown, WV, USA.
Kyle ChapmanWest Virginia University (WVU) Medicine, Morgantown, WV, USA.
Brijesh PatelWest Virginia University (WVU) Medicine, Morgantown, WV, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Mobile low-dose computed tomography (LDCT) lung screenings are part of an outreach program in rural Appalachia to detect early lung cancer. Coronary artery calcium (CAC) scoring on LDCT can identify calcium deposits in coronary arteries and can prompt consideration of risk modification for prevention of cardiovascular disease (CVD) events. It is not known if Lung CT Screening Reporting & Data System (Lung-RADS) scoring correlates with CAC scores. There is no clear guidance for patients undergoing LDCT screenings to receive follow-up regarding CAC or prevention of associated CVD risk. Methods: This was a retrospective review of mobile LDCT LCS in adults with no known history of CVD. CT images were obtained at 100 kVp with a slice thickness of 3 mm. Agatston CAC scoring was performed retroactively. Lung-RADS scores were categorized as: Negative (1), Benign (2), Probably Benign (3), and Suspicious (4). CAC scoring was grouped as 0, 1-100, 101-399, and ≥400. Descriptive statistics and chi-square analyses were utilized. Results: A total of 526 LDCT screenings were included. Over 54 % of patients had coronary calcification on LDCT LCS. 161 patients (30.6 %) had a CAC score of ≥100 and 75 patients (14.3 %) had a CAC score ≥400. Of patients with a CAC score ≥100, 7.5 % received referrals for follow-up after the LDCT screen and 9.3 % had additional cardiac testing. Of those with a CAC score ≥100 not already on a statin (45.3 %) and not already on aspirin (63.3 %), few were started within 3 months of LDCT for prevention (8.2 % and 5.9 % respectively). Among patients with a Lung-RADS score of 4, 17 % had a CAC score >400, whereas only 12 % with a Lung-RADS score of 1 fell into the same CAC category. Higher Lung-RADS scores correlated with fewer patients with CAC of 0. A significant correlation was observed between higher Lung-RADS scores and elevated CAC scores ( Conclusion: In patients with no CVD history, coronary artery calcification was frequently identified on mobile LDCT lung screenings in rural communities. Patients with higher probabilities of malignant lung nodules may also be at increased risk for significant coronary artery disease. Calcium scoring from LDCT screenings allowed for simultaneous assessment of lung cancer and CVD risk. Unfortunately, few referrals or CVD prevention medications were initiated. Awareness of CAC score utility, follow-up for identified coronary calcifications, and consideration of primary prevention medications when indicated, would be beneficial in patients undergoing LDCT lung screenings, especially in rural areas with limited healthcare access.

Indexed as

Cardiovascular disease preventionCoronary artery calcium scoreLung-RADS

Identifiers

PMID39252854
PMCPMC11381835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.